The causes of schizophrenia remain obscure and complex to identify. Alterations in
dopaminergic and serotonergic neurotransmission are, to date, the primary pharmacological …

Clozapine-induced myocarditis (CIM) is among the most important adverse events limiting
the use of clozapine as the most effective treatment for schizophrenia. CIM necessitates the …

The second-generation antipsychotic clozapine is used as a medication for treatment-
resistant schizophrenia. It has previously been associated with epigenetic changes in pre …

Immune dysfunction has been proposed to play a role in the pathophysiology behind the
development and persistence of psychosis. Current immunophenotyping studies are limited …

Clozapine is effective at reducing symptoms of treatment-resistant schizophrenia, but it can
also induce several adverse outcomes including neutropenia and agranulocytosis. We used …

Background: Recent research highlights the neuroimmunological basis of Schizophrenia
with an intrigue into biomarkers for Schizophrenia. Methods: It was a prospective …

Background: Immunological/inflammatory mechanisms may be involved in the
pathophysiology, in schizophrenia (SCZ) as well as in obsessivecompulsive disorder (OCD) …